Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients. [electronic resource]
Producer: 20201223Description: 274 p. digitalISSN:- 1745-6215
- Aerosols
- Bayes Theorem
- Clinical Trials, Phase III as Topic
- Deoxyribonuclease I -- administration & dosage
- Double-Blind Method
- Extracellular Traps -- drug effects
- Humans
- Hypoxia -- drug therapy
- Incidence
- Injury Severity Score
- Multicenter Studies as Topic
- Prospective Studies
- Randomized Controlled Trials as Topic
- Recombinant Proteins -- administration & dosage
- Respiration, Artificial -- adverse effects
- Respiratory Distress Syndrome -- drug therapy
- Wounds and Injuries -- physiopathology
No physical items for this record
Publication Type: Clinical Trial Protocol; Journal Article
There are no comments on this title.
Log in to your account to post a comment.